Off-Target Based Drug Repurposing Opportunities for Tivantinib in Acute Myeloid Leukemia
Scientific Reports - United Kingdom
doi 10.1038/s41598-018-37174-6
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 24, 2019
Authors
Publisher
Springer Science and Business Media LLC